-
Mashup Score: 0
April 5, 2022 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients in the U.S. with slow heart rhythms. This marks significant advancement for patient care and brings new, never-before-seen features to patients and their physicians. The Aveir leadless pacemaker is implanted directly inside…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0new wireless mini pacemaker - 4 year(s) ago
Mark Nicholls speaks to Dr Christophe Garweg about a first-in-Europe procedure and how a next-generation wireless mini-pacemaker will benefit more patients
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
@DAICeditor @AbbottCardio #Abbott’s #Aveir single chamber (#VR) pacing system is the world’s only #leadless #pacemaker with a unique mapping capability to assess correct positioning prior to placement: https://t.co/UufJGC7WGB